Global Immune Checkpoint Inhibitors Market Size, Share and Report Analysis By Drug Class (PD‑1 inhibitors, PD‑L1 inhibitors, CTLA‑4 inhibitors, Other) , By Cancer type (Lung Cancer (NSCLC/SCLC), Melanoma, Renal cell carcinoma, Bladder cancer, Head & neck cancers, Hodgkin lymphoma & other heme malignancies, Other solid tumors), By Route of Administration (Intravenous, Subcutaneous, Other routes), By End-user (Hospitals & hospital pharmacies, Specialty oncology clinics, Academic & research centers, Retail/other pharmacies & settings), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035